I can understand your uncertainty but information within the company is highly sensitive, until shits sorted and commercial availability commences. Ido made it very clear he didn’t want their capsules to be just another medication through the SAS. Clinical evaluation is what’s necessary (as per any current Pharma company that’s a billion dollar market cap) to drive trust in their brand.
no other company in Australia in my opinion has a decent formulation that has undergone clinical evaluation.
lets see how AusCann goes about it
revenue second half if capsules are out on time
AC8 Price at posting:
24.0¢ Sentiment: Buy Disclosure: Held
